In contrast, Devillier et al. reported positive results in only 8% of AML-MRC cases [35], while Falini et al. initially reported that NPM1 gene mutations were found only in de novo AML and not in the 135 AML cases arising from myelodysplasia [12]. This evidence concerns the gene NPM1 and acute myeloid leukemia.